IP Library Granted Patent US 8,007,823
Granted Patent B2
US 8,007,823 · App. 10/552,357 · Granted Aug 30, 2011

Microporous articles comprising biodegradable medical polymers, method of preparation thereof and method of use thereof

Assignee: Corporation de l'Ecole Polytechnique de Montreal
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,007,823
App. No.
10/552,357
Granted
Aug 30, 2011
Kind
B2
Abstract

The present invention relates to a highly controlled method of preparation of a microporous biodegradable polymeric article. Firstly, at least one biodegradable polymer A, one polymer B, biodegradable or not, partially or totally immiscible with A, and a compatibilizer C for A and B are selected. Secondly, the selected polymers are melt-blended, thereby preparing a polymer blend, wherein said polymers A and B have an essentially continuous morphology. Thirdly, after cooling, polymer B and compatibilizer C are selectively extracted from the polymer blend by dissolution in a solvent that is a non-solvent of polymer A. The resulting polymeric article has an essentially continuous porosity with a void volume between 10 and 90% and a unimodal diameter distribution set to a predefined unimodal peak location. It can be used in tissue engineering, for controlled release applications or as an implantable medical device.

Claims (53)

1. A microporous polymeric article having a target pore diameter d v , comprising an essentially continuous porosity with a controlled void volume from 10 to 90%, wherein pore diameters show a unimodal distribution set at a predefined unimodal peak location corresponding to said target pore diameter d v , and wherein a majority of pores have a diameter d of at least d v −50% and at most d v +50%, prepared according to a method comprising the steps of:

a) determining a target pore diameter d v ;

b) selecting at least one polymer A and at least one polymer B at least partially immiscible with A, according to the target pore diameter d v determined in step a);

c) melt blending the selected polymers from step b), thereby preparing a polymer blend, wherein said polymers A and B have an essentially continuous morphology;

d) cooling said polymer blend to room temperature, thereby retaining its morphology; and

e) extracting said polymer B, at least partially, from the polymer blend by dissolving said polymer B in a solvent that is a non-solvent of polymer A.

2. The microporous polymeric article according to claim 1 , wherein the target pore diameter d v is from 20 nm to 500 μm.

3. The microporous polymeric article according to claim 2 , wherein the target pore diameter d v is from 1 to 72 μm.

4. The microporous polymeric article according to claim 3 , wherein the majority of pores have a diameter d comprised in a range between d v −40% and d v +40%.

5. The microporous polymeric article according to claim 1 , wherein the target pore diameter d v is from 1 to 3 μm, and wherein the majority of pores have a diameter d comprised in a range between d v −25% and d v +25%.

6. The microporous biodegradable polymeric article according to claim 1 , wherein the porosity is fully continuous.

7. The microporous biodegradable polymeric article according to claim 1 , wherein the article has a symmetric morphology.

8. The microporous biodegradable polymeric article according to claim 1 , wherein the article has an asymmetric morphology.

9. The microporous biodegradable polymeric article according to claim 8 , wherein the article has a closed-cell skin.

10. The microporous biodegradable polymeric article according to claim 1 , wherein at least 95% of said article is made of a biodegradable medical polymer selected from the group consisting of poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic), polyorthoesters, polycaprolactones, polyanhydrides and their copolymers.

11. The microporous biodegradable polymeric article according to claim 1 , wherein at least 99% of said article is made of a biodegradable medical polymer selected from the group consisting of poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic), polyorthoesters, polycaprolactones, polyanhydrides and their copolymers.

12. The microporous biodegradable polymeric article according to claim 1 , wherein said article is essentially made of a biocompatible, implantable polymer.

13. A method of preparation of a microporous biodegradable polymeric article, comprising the steps:

a) selecting at least one biodegradable polymer A, one polymer B, biodegradable or not, at least partially immiscible with A, and a polymeric compatibilizer C for A and B;

b) melt blending the selected polymers from step a) and the compatibilizer C, thereby preparing a compatibilized polymer blend, wherein said polymers A and B have an essentially continuous morphology;

c) cooling said polymer blend to room temperature, thereby retaining its morphology; and

d) extracting said polymer B and said compatibilizer C, at least partially, from the polymer blend by dissolving them in a solvent that is a non-solvent of polymer A,

wherein said polymeric article has an essentially continuous porosity with a void volume from 10 to 90%, wherein pore diameters show a unimodal distribution set to a predefined unimodal peak location corresponding to a chosen pore diameter, and wherein a majority of pore has a diameter within ±50% of the chosen pore diameter.

14. The method according to claim 13 , wherein said polymer A is a biodegradable medical polymer.

15. The method according to claim 14 , wherein said polymer A is an aliphatic polyester.

16. The method according to claim 14 , wherein said polymer A is selected from the group consisting of poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic), poly(hydroxyalkanoates), polyorthoesters, polycaprolactones, polydioxanone, polyan hydrides and their copolymers.

17. The method according to claim 13 , wherein said polymer B is a non-biodegradable polymer.

18. The method according to claim 13 , wherein said polymer B is a biodegradable medical polymer.

19. The method according to claim 18 , wherein said polymer B is selected from a group consisting of poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic), poly(hydroxyalkanoates), polyorthoesters, polycaprolactones, polyanhydrides and their copolymers.

20. The method according to claim 13 , wherein said compatibilizer C is a polymeric compatibilizer.

21. The method according to claim 20 , wherein said compatibilizer C is a copolymer of A and B.

22. The method according to claim 13 , wherein said polymers A and B are fully immiscible.

23. The method according to claim 13 , wherein said polymer blend is co-continuous at more than 90%.

24. The method according to claim 13 , wherein said polymer blend may contain one or more additives.

25. The method according to claim 13 , wherein said polymer blend is submitted to a further step of controlled annealing between steps b) and c), thereby increasing the pore size of the porous article.

26. The method according to claim 13 , wherein said polymer blend is submitted to controlled cooling rates in step c).

27. The method according to claim 13 , wherein said polymer blend is further shaped into a geometrical form between steps b) and c).

28. The method according to claim 27 , wherein said polymer blend is further shaped in a mold or die, between steps b) and c).

29. The method according to claim 27 , wherein said polymer blend is shaped by injection molding, between steps b) and c).

30. The method according to claim 27 , wherein said polymer blend is formed by extrusion, between steps b) and c).

31. The method according to claim 27 , wherein said polymer blend is formed by melt spinning between steps b) and c).

32. The method according to claim 13 , wherein said polymer blend is submitted to a mechanical stress that orients the porosity in at least one specific direction, between steps b) and c).

33. The method according to claim 13 , wherein said polymer blend is submitted to a mechanical stress that orients the porosity in at least one specific direction, during step c).

34. The method according to claim 13 , wherein said polymeric article is further submitted to a controlled immersion in a solvent for its polymer A after step d), thereby creating a closed-cell skin.

35. The method according to claim 13 , wherein said polymer blend is further submitted to a controlled immersion in a common solvent for A and B between steps c) and d), thereby creating an asymmetric open-cell morphology in the porous article.

36. A method of tissue engineering utilizing a microporous article according to any one of claims 2 to 5 and 1 .

37. The microporous biodegradable article obtained by the method according to any of claims 13 - 35 , wherein said microporous biodegradable article is tissue engineering article.

38. A method of controlled release utilizing a microporous article according to any one of claims 2 to 5 and 1 as a substrate.

39. The microporous biodegradable article obtained by the method according to any of claims 13 - 35 , wherein said microporous biodegradable article is a substrate for controlled release applications.

40. A method of forming an implantable medical device utilizing a microporous article according to any one of claims 2 to 5 and 1 .

41. The microporous biodegradable article obtained by the method according to any of claims 13 - 35 , wherein said microporous biodegradable article is an implantable medical device.

42. The microporous polymeric article according to any one of claims 2 to 5 , said article being biodegradable.

43. The microporous polymeric article according to claim 1 , wherein step b) further comprises selecting a polymeric compatibilizer C for A and B; step c) comprises melt blending the selected polymers from step a) and the compatibilizer C, thereby preparing a compatibilized polymer blend; and step e) comprises extracting said polymer B and said compatibilizer C, at least partially, from the polymer blend by dissolving them in a solvent that is a non-solvent of polymer A.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2006
From: FAVIS, BASIL D.; SARAZIN, PIERRE; LI, JIANMING; YUAN, ZHENHUA
To: CORPORATION DE L'ECOLE POLYTECHNIQUE DE MONTREAL
Reel/Frame 018118/0259 →
Continuity (2)
Provisional Application 60459635 · Apr 3, 2003
Related Publication 20070116737A1 · May 24, 2007